Henry Schein (NASDAQ:HSIC – Get Free Report) and Field Trip Health (OTCMKTS:FTRPF – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.
Analyst Recommendations
This is a summary of recent ratings and target prices for Henry Schein and Field Trip Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Henry Schein | 1 | 5 | 9 | 0 | 2.53 |
| Field Trip Health | 0 | 0 | 0 | 0 | 0.00 |
Henry Schein presently has a consensus price target of $92.93, indicating a potential upside of 3.66%. Given Henry Schein’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Henry Schein is more favorable than Field Trip Health.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Henry Schein | 2.96% | 15.97% | 5.56% |
| Field Trip Health | N/A | N/A | N/A |
Valuation & Earnings
This table compares Henry Schein and Field Trip Health”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Henry Schein | $13.18 billion | 0.76 | $398.00 million | $3.43 | 26.14 |
| Field Trip Health | N/A | N/A | N/A | N/A | N/A |
Henry Schein has higher revenue and earnings than Field Trip Health.
Insider & Institutional Ownership
96.6% of Henry Schein shares are held by institutional investors. 0.9% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Summary
Henry Schein beats Field Trip Health on 9 of the 9 factors compared between the two stocks.
About Henry Schein
Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
About Field Trip Health
Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies. Its Research division is involved in the development of psychedelic molecules and conducting research on plant-based psychedelics. The company also operates Field Trip Health clinics for psychedelic therapies in North America. Its Technology division engages in building digital and technological tools to support psychedelic experiences and consciousness expansion. Field Trip Health Ltd. is headquartered in Toronto, Canada.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.
